DANIEL K. SPIEGELMAN - Director at Maze Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
MAZE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by DANIEL K. SPIEGELMAN since 07 Feb 2025

Holdings reported by DANIEL K. SPIEGELMAN for Maze Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 18,000 22 Sep 2025 Direct Common Stock

Transactions reported by DANIEL K. SPIEGELMAN for Maze Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.